Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
E-pub ahead of print

Patient ambassador support in newly diagnosed patients with acute leukemia during treatment: a feasibility study

Research output: Contribution to journalJournal articleResearchpeer-review

  1. The HemoScreen hematology point-of-care device is suitable for rapid evaluation of acute leukemia patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Psychometric validity and reliability of the Danish version of the MD Anderson Symptom Inventory Brain Tumor Module

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

PURPOSE: This study investigated the feasibility of patient ambassador support in newly diagnosed patients with acute leukemia during treatment.

METHODS: A multicenter single-arm feasibility study that included patients newly diagnosed with acute leukemia (n = 36) and patient ambassadors previously treated for acute leukemia (n = 25). Prior to the intervention, all patient ambassadors attended a 6-h group training program. In the intervention, patient ambassadors provided 12 weeks of support for patients within 2 weeks of being diagnosed. Outcome measures included feasibility (primary outcome), safety, anxiety, and depression measured by the Hospital Anxiety and Depression Scale, quality of life by the Functional Assessment of Cancer Therapy-Leukemia and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire, and symptom burden by MD Anderson Symptom Inventory, the Patient Activation Measure, and the General Self-Efficacy Scale.

RESULTS: Patient ambassador support was feasible and safe in this population. Patients and patient ambassadors reported high satisfaction with the individually adjusted support, and patients improved in psychosocial outcomes over time. Patient ambassadors maintained their psychosocial baseline level, with no adverse events, and used the available support to exchange experiences with other patient ambassadors and to manage challenges.

CONCLUSION: The patient ambassador support program is feasible and has the potential to be a new model of care incorporated in the hematology clinical care setting, creating an active partnership between patients and former patients. This may strengthen the existing supportive care services for patients with acute leukemia.

TRIAL REGISTRATION: NCT03493906.

Original languageEnglish
JournalSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN0941-4355
DOIs
Publication statusE-pub ahead of print - 2021

    Research areas

  • Peer support, Patient ambassador, Acute leukemia, Supportive care, Feasibility, Psychosocial

ID: 61264034